US Stock MarketDetailed Quotes

ETON Eton Pharmaceutical

Watchlist
  • 3.600
  • -0.060-1.64%
Close May 23 16:00 ET
92.49MMarket Cap120.00P/E (TTM)

Eton Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-59.75%-2.47M
41.36%6.82M
-86.37%387K
151.26%873K
188.62%7.1M
-226.57%-1.55M
202.12%4.82M
155.50%2.84M
42.27%-1.7M
766.94%2.46M
Net income from continuing operations
69.51%-811K
89.62%-936K
-347.37%-2.26M
80.99%-579K
392.62%4.56M
50.09%-2.66M
-361.43%-9.02M
-12.22%912K
50.03%-3.05M
22.72%-1.56M
Depreciation and amortization
18.31%252K
-49.21%901K
9.13%275K
18.82%202K
-81.98%211K
17.68%213K
283.98%1.77M
83.94%252K
100.00%170K
1,277.65%1.17M
Other non cash items
-13.79%25K
-7.87%117K
-12.90%27K
-3.33%29K
6.67%32K
-19.44%29K
-14.19%127K
-18.42%31K
-18.92%30K
-18.92%30K
Change In working capital
-137,900.00%-2.76M
-53.44%3.6M
109.62%1.59M
154.40%491K
-0.13%1.52M
-100.04%-2K
224.34%7.72M
110.55%759K
-90.41%193K
22.91%1.52M
-Change in receivables
18.88%-829K
-143.08%-1.56M
123.73%84K
38.10%-411K
-452.63%-210K
-121.86%-1.02M
166.73%3.62M
93.04%-354K
-709.76%-664K
-1,166.67%-38K
-Change in inventory
-1,272.50%-1.41M
-4,957.14%-354K
284.21%140K
-570.00%-235K
-1,704.76%-379K
200.00%120K
-101.01%-7K
64.81%-76K
-94.49%50K
-119.81%-21K
-Change in prepaid assets
-58.64%79K
-91.54%161K
-159.03%-588K
7.95%326K
-73.21%232K
-80.12%191K
285.38%1.9M
69.45%-227K
143.02%302K
-31.54%866K
-Change in payables and accrued expense
-185.05%-603K
142.10%5.35M
38.06%1.96M
60.59%811K
163.43%1.87M
267.61%709K
586.56%2.21M
223.24%1.42M
-73.27%505K
634.59%711K
Cash from discontinued investing activities
Operating cash flow
-59.75%-2.47M
41.36%6.82M
-86.37%387K
151.26%873K
188.62%7.1M
-226.57%-1.55M
202.12%4.82M
155.50%2.84M
42.27%-1.7M
766.94%2.46M
Investing cash flow
Cash flow from continuing investing activities
-1.88M
72.20%-775K
-6,358.33%-775K
0
0
0
-8.95%-2.79M
99.63%-12K
-99,900.00%-2M
-209.18%-761K
Net PPE purchase and sale
---14K
--0
--0
--0
--0
--0
-105.50%-38K
-200.00%-12K
--0
-101.58%-11K
Net intangibles purchase and sale
---1.87M
71.82%-775K
---775K
--0
--0
--0
15.38%-2.75M
--0
---2M
----
Cash from discontinued investing activities
Investing cash flow
---1.88M
72.20%-775K
-6,358.33%-775K
--0
--0
--0
-8.95%-2.79M
99.63%-12K
-99,900.00%-2M
-209.18%-761K
Financing cash flow
Cash flow from continuing financing activities
-671.43%-378K
-614.18%-957K
-396.97%-294K
-1,151.43%-368K
-310.26%-246K
87.27%-49K
-134.27%-134K
45.59%99K
124.82%35K
-67.59%117K
Net issuance payments of debt
---385K
-200.00%-1.16M
---385K
---385K
---385K
--0
-156.67%-385K
--0
--0
--0
Proceeds from stock option exercised by employees
-94.70%7K
-21.12%198K
-190.91%-90K
-51.43%17K
18.80%139K
--132K
-53.60%251K
45.59%99K
288.89%35K
-67.59%117K
Net other financing activities
----
----
----
--0
--0
---181K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-671.43%-378K
-614.18%-957K
-396.97%-294K
-1,151.43%-368K
-310.26%-246K
87.27%-49K
-134.27%-134K
45.59%99K
124.82%35K
-67.59%117K
Net cash flow
Beginning cash position
31.17%21.39M
13.18%16.31M
64.97%22.07M
26.52%21.57M
-3.42%14.71M
13.18%16.31M
-32.35%14.41M
-41.09%13.38M
-33.94%17.05M
-39.36%15.23M
Current changes in cash
-196.37%-4.73M
167.67%5.08M
-123.30%-682K
113.74%504K
277.44%6.86M
-294.05%-1.6M
127.57%1.9M
135.25%2.93M
-18.59%-3.67M
163.72%1.82M
End cash Position
13.24%16.66M
31.17%21.39M
31.17%21.39M
64.97%22.07M
26.52%21.57M
-3.42%14.71M
13.18%16.31M
13.18%16.31M
-41.09%13.38M
-33.94%17.05M
Free cash flow
-181.33%-4.36M
197.10%6.04M
-113.72%-388K
123.58%873K
317.82%7.1M
-228.15%-1.55M
125.48%2.03M
133.78%2.83M
-25.44%-3.7M
556.99%1.7M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -59.75%-2.47M41.36%6.82M-86.37%387K151.26%873K188.62%7.1M-226.57%-1.55M202.12%4.82M155.50%2.84M42.27%-1.7M766.94%2.46M
Net income from continuing operations 69.51%-811K89.62%-936K-347.37%-2.26M80.99%-579K392.62%4.56M50.09%-2.66M-361.43%-9.02M-12.22%912K50.03%-3.05M22.72%-1.56M
Depreciation and amortization 18.31%252K-49.21%901K9.13%275K18.82%202K-81.98%211K17.68%213K283.98%1.77M83.94%252K100.00%170K1,277.65%1.17M
Other non cash items -13.79%25K-7.87%117K-12.90%27K-3.33%29K6.67%32K-19.44%29K-14.19%127K-18.42%31K-18.92%30K-18.92%30K
Change In working capital -137,900.00%-2.76M-53.44%3.6M109.62%1.59M154.40%491K-0.13%1.52M-100.04%-2K224.34%7.72M110.55%759K-90.41%193K22.91%1.52M
-Change in receivables 18.88%-829K-143.08%-1.56M123.73%84K38.10%-411K-452.63%-210K-121.86%-1.02M166.73%3.62M93.04%-354K-709.76%-664K-1,166.67%-38K
-Change in inventory -1,272.50%-1.41M-4,957.14%-354K284.21%140K-570.00%-235K-1,704.76%-379K200.00%120K-101.01%-7K64.81%-76K-94.49%50K-119.81%-21K
-Change in prepaid assets -58.64%79K-91.54%161K-159.03%-588K7.95%326K-73.21%232K-80.12%191K285.38%1.9M69.45%-227K143.02%302K-31.54%866K
-Change in payables and accrued expense -185.05%-603K142.10%5.35M38.06%1.96M60.59%811K163.43%1.87M267.61%709K586.56%2.21M223.24%1.42M-73.27%505K634.59%711K
Cash from discontinued investing activities
Operating cash flow -59.75%-2.47M41.36%6.82M-86.37%387K151.26%873K188.62%7.1M-226.57%-1.55M202.12%4.82M155.50%2.84M42.27%-1.7M766.94%2.46M
Investing cash flow
Cash flow from continuing investing activities -1.88M72.20%-775K-6,358.33%-775K000-8.95%-2.79M99.63%-12K-99,900.00%-2M-209.18%-761K
Net PPE purchase and sale ---14K--0--0--0--0--0-105.50%-38K-200.00%-12K--0-101.58%-11K
Net intangibles purchase and sale ---1.87M71.82%-775K---775K--0--0--015.38%-2.75M--0---2M----
Cash from discontinued investing activities
Investing cash flow ---1.88M72.20%-775K-6,358.33%-775K--0--0--0-8.95%-2.79M99.63%-12K-99,900.00%-2M-209.18%-761K
Financing cash flow
Cash flow from continuing financing activities -671.43%-378K-614.18%-957K-396.97%-294K-1,151.43%-368K-310.26%-246K87.27%-49K-134.27%-134K45.59%99K124.82%35K-67.59%117K
Net issuance payments of debt ---385K-200.00%-1.16M---385K---385K---385K--0-156.67%-385K--0--0--0
Proceeds from stock option exercised by employees -94.70%7K-21.12%198K-190.91%-90K-51.43%17K18.80%139K--132K-53.60%251K45.59%99K288.89%35K-67.59%117K
Net other financing activities --------------0--0---181K----------------
Cash from discontinued financing activities
Financing cash flow -671.43%-378K-614.18%-957K-396.97%-294K-1,151.43%-368K-310.26%-246K87.27%-49K-134.27%-134K45.59%99K124.82%35K-67.59%117K
Net cash flow
Beginning cash position 31.17%21.39M13.18%16.31M64.97%22.07M26.52%21.57M-3.42%14.71M13.18%16.31M-32.35%14.41M-41.09%13.38M-33.94%17.05M-39.36%15.23M
Current changes in cash -196.37%-4.73M167.67%5.08M-123.30%-682K113.74%504K277.44%6.86M-294.05%-1.6M127.57%1.9M135.25%2.93M-18.59%-3.67M163.72%1.82M
End cash Position 13.24%16.66M31.17%21.39M31.17%21.39M64.97%22.07M26.52%21.57M-3.42%14.71M13.18%16.31M13.18%16.31M-41.09%13.38M-33.94%17.05M
Free cash flow -181.33%-4.36M197.10%6.04M-113.72%-388K123.58%873K317.82%7.1M-228.15%-1.55M125.48%2.03M133.78%2.83M-25.44%-3.7M556.99%1.7M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg